Showing results (321-330 of 396) with videos related to

Sort By:
Pageof 40
Diabetes Care|September 15, 2023
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE TrialDennis I Narcisse, Hwasoon Kim, Lisa M Wruck, et al.
JAMA Cardiology|October 4, 2023
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical TrialAmber Sleem, Mark B Effron, Amanda Stebbins, et al.
Vascular Medicine (London, England)|October 17, 2024
Quantifying patients' preferences on tradeoffs between mortality risk and reduced need for target vessel revascularization for claudicationShelby D Reed, Jessie Sutphin, Matthew J Wallace, et al.
The Journal of Trauma and Acute Care Surgery|August 19, 2016
Open chest cardiac massage offers no benefit over closed chest compressions in patients with traumatic cardiac arrestMatthew J Bradley, Brandon W Bonds, Luke Chang, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|April 25, 2019
Arterial waveform morphomics during hemorrhagic shockPhilip J Wasicek, William A Teeter, Shiming Yang, et al.
Frontiers in Neurology|October 16, 2018
Continuous Vital Sign Analysis to Predict Secondary Neurological Decline After Traumatic Brain InjuryChristopher Melinosky, Shiming Yang, Peter Hu, et al.
Leukemia & Lymphoma|November 6, 2019
The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparisonMaria-Victoria Mateos, Jesus San-Miguel, Hartmut Goldschmidt, et al.
European Journal of Heart Failure|December 26, 2024
Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trialMark C Petrie, Jacob A Udell, Stefan D Anker, et al.
JAMA Network Open|June 26, 2024
Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 DiabetesDaniel Edmonston, Elizabeth Lydon, Hillary Mulder, et al.
American Heart Journal|June 8, 2023
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLEKamal Gupta, Harsh Mehta, Hwasoon Kim, et al.
Pageof 40